C T Minson1, J R Halliwill, T M Young, M J Joyner. 1. Department of Anesthesiology and General Clinical Research Center, Mayo Clinic and Foundation, Rochester, MN 55905, USA. minson.christopher@mayo.edu
Abstract
BACKGROUND: We tested sympathetic and cardiovagal baroreflex sensitivity during the placebo or "low-hormone" phase (LH) and 2 to 3 weeks later during the "high-hormone" phase (HH) of oral contraceptive (OC) use in 9 women. METHODS AND RESULTS: Sympathetic baroreflex sensitivity was assessed by intravenous doses of sodium nitroprusside and phenylephrine and defined as the slope relating muscle sympathetic nerve activity (by microneurography) and diastolic blood pressure. Cardiovagal baroreflex sensitivity was defined as the slope relating R-R interval and systolic blood pressure. No difference was observed for resting muscle sympathetic nerve activity or plasma norepinephrine levels. However, sympathetic baroreflex sensitivity was greater and mean arterial pressure was higher during the LH than in the HH phase. Similarly, cardiovagal baroreflex sensitivity was greater in the LH than in the HH phase. CONCLUSIONS: Sympathetic and cardiovagal baroreflex sensitivities change during the 28-day course of OC use. Furthermore, changes in baroreflex sensitivity with OC differ from changes in baroreflex sensitivity during the normal menstrual cycle.
BACKGROUND: We tested sympathetic and cardiovagal baroreflex sensitivity during the placebo or "low-hormone" phase (LH) and 2 to 3 weeks later during the "high-hormone" phase (HH) of oral contraceptive (OC) use in 9 women. METHODS AND RESULTS: Sympathetic baroreflex sensitivity was assessed by intravenous doses of sodium nitroprusside and phenylephrine and defined as the slope relating muscle sympathetic nerve activity (by microneurography) and diastolic blood pressure. Cardiovagal baroreflex sensitivity was defined as the slope relating R-R interval and systolic blood pressure. No difference was observed for resting muscle sympathetic nerve activity or plasma norepinephrine levels. However, sympathetic baroreflex sensitivity was greater and mean arterial pressure was higher during the LH than in the HH phase. Similarly, cardiovagal baroreflex sensitivity was greater in the LH than in the HH phase. CONCLUSIONS: Sympathetic and cardiovagal baroreflex sensitivities change during the 28-day course of OC use. Furthermore, changes in baroreflex sensitivity with OC differ from changes in baroreflex sensitivity during the normal menstrual cycle.
Authors: Qi Fu; Tiffany B VanGundy; Shigeki Shibata; Richard J Auchus; Gordon H Williams; Benjamin D Levine Journal: Hypertension Date: 2010-05-17 Impact factor: 10.190
Authors: Charlotte W Usselman; Chantelle A Nielson; Torri A Luchyshyn; Tamara I Gimon; Nicole S Coverdale; Stan H M Van Uum; J Kevin Shoemaker Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-10-12 Impact factor: 3.619
Authors: Rachel E Engelland; Holden W Hemingway; Olivia G Tomasco; Albert H Olivencia-Yurvati; Steven A Romero Journal: Am J Physiol Heart Circ Physiol Date: 2020-03-06 Impact factor: 4.733
Authors: Sarah E Baker; Jacqueline K Limberg; Sushant M Ranadive; Michael J Joyner Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-11-16 Impact factor: 3.619
Authors: Qi Fu; Kazunobu Okazaki; Shigeki Shibata; Robin P Shook; Tiffany B VanGunday; M Melyn Galbreath; Miriam F Reelick; Benjamin D Levine Journal: J Physiol Date: 2009-02-23 Impact factor: 5.182